The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 31, 2023

Filed:

Apr. 08, 2019
Applicants:

Fundación Pública Andaluza Progreso Y Salud, Seville, ES;

Servicio Andaluz DE Salud, Seville, ES;

Inventors:

Rafael Campos Cuerva, Seville, ES;

Beatriz Fernandez Muñoz, Seville, ES;

Miguel Angel Gómez Bravo, Seville, ES;

Carmen Cepeda Franco, Seville, ES;

Jordi Muntane Relat, Seville, ES;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61L 24/00 (2006.01); A61L 24/04 (2006.01); A61L 26/00 (2006.01); A61L 31/14 (2006.01);
U.S. Cl.
CPC ...
A61L 24/0042 (2013.01); A61L 24/0031 (2013.01); A61L 24/043 (2013.01); A61L 26/008 (2013.01); A61L 26/009 (2013.01); A61L 26/0052 (2013.01); A61L 31/145 (2013.01); A61L 31/148 (2013.01); A61L 2400/04 (2013.01); A61L 2400/12 (2013.01);
Abstract

The present invention provides for nanostructured fibrin and agarose hydrogels, preferably type VII agarose hydrogels, (NFAH) or non-nanostructured or pre-nanostructured fibrin and agarose hydrogels, preferably type VII agarose hydrogels, (FAH), as hemostatic agents designed for use as an adjunct or primary treatment in moderate intraoperative hemorrhage and in trauma. These hydrogels can be applied topically to the wound either on the skin in a laparotomy or as non-invasive manner in surgical procedures. Its nanostructure technology generates an adhesive stable fibrin clot required for hemostasis. The attachment properties of the hydrogel, as well as the rapid formation of a fibrin clot, ensures that a strong stable fibrin clot is formed shortly after application.


Find Patent Forward Citations

Loading…